Systemic Treatment with Erythropoietin Protects the Neurovascular Unit in a Rat Model of Retinal Neurodegeneration
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Treatment with Erythropoietin Protects the Neurovascular Unit in a Rat Model of Retinal Neurodegeneration
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 7, Pages e102013
Publisher
Public Library of Science (PLoS)
Online
2014-07-12
DOI
10.1371/journal.pone.0102013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL
- (2016) Yan Chen Shang et al. Aging-US
- Endogenous Erythropoietin Protects Neuroretinal Function in Ischemic Retinopathy
- (2012) Freya M. Mowat et al. AMERICAN JOURNAL OF PATHOLOGY
- Alzheimers Disease and Retinal Neurodegeneration Share a Consistent Stress Response of the Neurovascular Unit
- (2012) Stephanie Busch et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats
- (2012) Junko Mitsuhashi et al. EXPERIMENTAL EYE RESEARCH
- Acute erythropoietin cardioprotection is mediated by endothelial response
- (2011) Ruifeng Teng et al. BASIC RESEARCH IN CARDIOLOGY
- Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy
- (2011) Qian Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: Essential role of JAK2/ PI3K signaling
- (2011) Marta Garcia-Ramírez et al. CELLULAR SIGNALLING
- Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy
- (2011) Carmel M. McVicar et al. DIABETES
- Effects of erythropoietin on angiogenesis after myocardial infarction in porcine
- (2011) Keisuke Kawachi et al. HEART AND VESSELS
- Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia
- (2011) Rhonda Souvenir et al. NEUROBIOLOGY OF DISEASE
- Gene Expression Profiling of Vasoregression in the Retina—Involvement of Microglial Cells
- (2011) Yuxi Feng et al. PLoS One
- Erythropoietin Enhances Nerve Repair in Anti-Ganglioside Antibody-Mediated Models of Immune Neuropathy
- (2011) Gang Zhang et al. PLoS One
- Erythropoietin therapy for early diabetic retinopathy through its protective effects on retinal pericytes
- (2010) Zhao-Yang Wang et al. MEDICAL HYPOTHESES
- Erythropoiesis stimulating agents, thrombosis and cancer
- (2010) Lisa Barbera et al. RADIOTHERAPY AND ONCOLOGY
- Thrombotic Complications of Erythropoiesis-Stimulating Agents
- (2010) Giuseppe Lippi et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Erythropoietin-induced upregulation of endothelial nitric oxide synthase but not vascular endothelial growth factor prevents musculocutaneous tissue from ischemic damage
- (2009) Farid Rezaeian et al. LABORATORY INVESTIGATION
- Vasoregression Linked to Neuronal Damage in the Rat with Defect of Polycystin-2
- (2009) Yuxi Feng et al. PLoS One
- Pericyte Migration: A Novel Mechanism of Pericyte Loss in Experimental Diabetic Retinopathy
- (2008) F. Pfister et al. DIABETES
- Expression of Erythropoietin and Its Receptor in the Human Retina: A comparative study of diabetic and nondiabetic subjects
- (2008) M. Garcia-Ramirez et al. DIABETES CARE
- Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin
- (2008) M. Brines et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More